Pharmafile Logo
Pharmafocus logo
Advanced Search

Takeda

Showing 15 posts of 249 posts found.

Astrazeneca image

Senior heads depart AstraZeneca and Takeda

June 25, 2015
Medical Communications, Sales and Marketing AstraZeneca, Briggs Morrison, François-Xavier Roger, James Ward-Lilley, Takeda, brett wells

AstraZeneca vice president James Ward-Lilley and Takeda’s chief financial officer François-Xavier Roger are both exiting their respective companies and moving …

News
lilly

Two new diabetes drugs approved

May 28, 2015
Sales and Marketing Japan, Takeda, diabetes in China, lilly

Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …

News
screen_shot_2015-05-18_at_07

Takeda appoints new business unit director

May 18, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, craig adkins

Takeda UK has appointed Craig Adkins as the new director of its its inflammatory bowel disease (IBD) business unit. Adkins …

Appointment
contrave

Takeda hits major snags with Contrave and Alisertib

May 14, 2015
Sales and Marketing Contrave, Takeda, alisertib, obesity, orexigen

Takeda is threatening to end its partnership with Orexigen to market the obesity drug Contrave, as allegations around its heart …

News
Takeda image

Takeda announces new cancer collaboration

May 11, 2015
Research and Development, Sales and Marketing Cancer, Europe, Takeda, mental health, ncc

Takeda will be teaming up with Japan’s National Cancer Center (NCC) to develop new cancer drugs. The two organisations have …

News
Actos image

Takeda pays $2.7 billion to settle Actos lawsuits

May 1, 2015
Sales and Marketing Actos, FDA, Takeda, bladder, lilly, pioglitazone, type 2

Takeda has agreed to pay $2.7 billion to finally settle thousands of US lawsuits claiming its diabetes drug Actos can …

News
FDA image

AZ and Takeda diabetes drugs get FDA safety update

April 15, 2015
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, diabetes, saxagliptin

An FDA advisory committee has said that the labels of two type 2 diabetes drugs should be changed to warn …

News
Astrazeneca image

AstraZeneca diabetes drug could ‘significantly’ increase mortality

April 13, 2015
Research and Development, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, saxagliptin

AstraZeneca’s diabetes drug Onglyza may lead to a ‘significant increase’ in risk of death according to a new analysis from …

News
Dubai skyline

Takeda expands in the United Arab Emirates

April 7, 2015
Medical Communications, Sales and Marketing Dubai, NEMEA, Singapore, Takeda, UAE, United Arab Emirates, near east

Takeda has opened new UAE offices in Dubai amidst plans to expand its business in the Middle East. The Japanese …

News
Actos image

Takeda offers $2.2 billion to resolve Actos damages claims

April 1, 2015
Sales and Marketing Actos, Cancer, Takeda, bladder, diabetes, heart, pioglitazone

Takeda has attempted to settle its hefty damages bill over claims it was hiding cancer risks in its diabetes drug …

News
Genome image

Big pharma teams with government on genomic research

March 27, 2015
Research and Development, Sales and Marketing AbbVie, Alexion Pharmaceuticals, AstraZeneca, Biogen, Cameron, Dimension Therapeutics, GSK, Genomic, Genomics england, Helomics, Roche, Takeda, UCB, UK, genomes

Ten firms will partner up with Genomics England to develop new diagnostics and treatments for people with rare diseases and …

News
Takeda image

Takeda buys license to ImmunoGen cancer tech

March 24, 2015
Research and Development, Sales and Marketing ADC, Immunogen, Takeda, antibody, conjugate, merger

Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …

News
Takeda HQ, Tokyo image

Takeda gets NICE nod for bowel treatment

March 13, 2015
Sales and Marketing NHS, NICE, Takeda, enyyvio, vedolizumab

Takeda’s Entyvio becomes the first NICE approved gut-selective treatment for UK patients with ulcerative colitis (UC) – a long-term condition …

News
GSK image

GSK picks Singapore for Asian hub

March 12, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Asia, GSK, Singapore, Takeda, Witty, emerging markets

Despite GlaxoSmithKline’s ongoing troubles in Asia it has decided to establish a new HQ in Singapore to bolster its presence …

News
Christophe Weber image

New chief executive for Takeda

March 4, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actos, Millennium, Nycomed, Takeda, Yasuchika Hasegawa, christophe weber

Japanese pharma giant Takeda has added the title of chief executive to its representative director, president and chief operating officer …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025